Scholar Rock to Present at the 2021 Wedbush PacGrow Healthcare Conference

Rhea-AI Summary

Scholar Rock (NASDAQ: SRRK) announced its participation in the 2021 Wedbush PacGrow Healthcare Conference on August 11, 2021, at 9:10 a.m. ET. Interested parties can access a live webcast through the Investors & Media section of its website. An archived version will be available for 90 days post-presentation. The company focuses on treating serious diseases related to protein growth factors, developing novel therapies for conditions such as neuromuscular disorders, cancer, and fibrosis. More information can be found at scholarrock.com.

Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that management will present at the 2021 Wedbush PacGrow Healthcare Conference on Wednesday, August 11^th, 2021 at 9:10 a.m. ET.

A live webcast of the presentation may be accessed by visiting the Investors & Media section of the Scholar Rock website at http://investors.scholarrock.com. An archived replay of the webcast will be available on the Company’s website for approximately 90 days following the presentation.

About Scholar Rock

Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Scholar Rock is creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including neuromuscular disorders, cancer, fibrosis and anemia. Scholar Rock’s approach to targeting the molecular mechanisms of growth factor activation enabled it to develop a proprietary platform for the discovery and development of monoclonal antibodies that locally and selectively target these signaling proteins at the cellular level. By developing product candidates that act in the disease microenvironment, the Company intends to avoid the historical challenges associated with inhibiting growth factors for therapeutic effect. Scholar Rock believes its focus on biologically validated growth factors may facilitate a more efficient development path. For more information, please visit https://scholarrock.com/ or follow Scholar Rock on Twitter (@ScholarRock) and LinkedIn (https://www.linkedin.com/company/scholar-rock/).

Scholar Rock® is a registered trademark of Scholar Rock, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210805005905/en/

FAQ

What is the date and time of Scholar Rock's presentation at the 2021 Wedbush PacGrow Healthcare Conference?

Scholar Rock will present on August 11, 2021, at 9:10 a.m. ET.

How can I access the live webcast of Scholar Rock's conference presentation?

The live webcast can be accessed through the Investors & Media section of Scholar Rock's website.

Will there be a recording of the Scholar Rock presentation available after the event?

Yes, an archived replay will be available on Scholar Rock's website for approximately 90 days.

What type of diseases does Scholar Rock focus on treating?

Scholar Rock focuses on serious diseases related to protein growth factors, including neuromuscular disorders, cancer, and fibrosis.

What is the stock symbol for Scholar Rock?

Scholar Rock trades under the stock symbol SRRK on NASDAQ.